Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Shares withheld for taxes Chief Executive Officer gave up 779 shares (to pay taxes)
  10. 4 Open-market sale CBO & COO sold 100,000 shares at an average $128.05 ($12,805,240)
  11. 4 Open-market sale Director sold 30,374 shares at an average $132.37 ($4,020,667)
  12. 4 Shares withheld for taxes Chief Financial Officer gave up 1,352 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 5,526 shares (to pay taxes)
  14. 4 Shares withheld for taxes CBO & COO gave up 2,141 shares (to pay taxes)
  15. 4 Shares withheld for taxes General Counsel and Secretary gave up 1,353 shares (to pay taxes)
  16. 4 Shares withheld for taxes Executive VP, Head of R&D gave up 2,141 shares (to pay taxes)
  17. 4/A Exercise or conversion CBO & COO acquired 16,334 shares (option exercise)
  18. 4 Shares withheld for taxes Executive VP, Head of R&D gave up 1,585 shares (to pay taxes)
  19. 4 Other disposition Director disposed of 338,165 shares (other)
  20. 4 Shares withheld for taxes Chief Executive Officer gave up 798 shares (to pay taxes)

Page 12 of 26 · 502 filings